Selective PDE4D inhibitor shows potential to treat Fragile X autism spectrum disorder
New preclinical research suggests the potential utility of BPN14770, a selective PDE4D inhibitor currently under development by Tetra Discovery Partners as a prospective treatment for memory and cognitive problems associated ...
Nov 7, 2017
0
6